A commercially available oral cannabis oil — containing two natural compounds found in the plant, one with psychoactive properties — appeared to be generally safe for people with Parkinson’s disease, but failed to reduce pain or ease other symptoms among participants in a small mid-stage clinical trial. The tested oil contains both cannabidiol (CBD) and tetrahydrocannabinol (THC), the compound in cannabis that causes a high and has been suggeste…